| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Revenue | $408.1M | +17.7% |
| Cost of Revenue | $263.4M | +18.4% |
| Gross Profit | $144.7M | +16.6% |
| R&D Expense | $36.4M | +46.2% |
| SG&A Expense | $85.0M | +21.8% |
| Operating Income | $19.4M | -26.5% |
| Pre-tax Income | $16.9M | -26.8% |
| Income Tax | $6.1M | -46.9% |
| Net Income | $10.8M |
| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.6M | +190.5% |
| Accounts Receivable | $158.0M | +55.4% |
| Current Assets | $405.2M | +70.5% |
| Total Assets | $535.2M | +46.8% |
| Current Liabilities | $218.9M | +68.3% |
| Long-term Debt | $48.4M | — |
| Total Liabilities | $279.3M | +93.5% |
| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.5M | +1957.7% |
| Capital Expenditures | $2.7M | -49.9% |
| Investing Cash Flow | -$35.2M | -194.8% |
| Financing Cash Flow | $48.7M | +7251.4% |
| Free Cash Flow | $27.9M | +499.3% |
| -6.7% |
| EPS (Basic) | $0.88 | -12.9% |
| EPS (Diluted) | $0.86 | -11.3% |
| Stockholders' Equity |
| $255.9M |
| +16.3% |